Drugs
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 04/28/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 04/27/15 -- Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and ...
BOTHELL, WA: Company Granted EP Process Patent and Four National Patents Covering Its tkRNAi, SMARTICLES and DILA2 Delivery Technologies ...
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 04/23/15 -- Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds, sca ...
AIX-EN-PROVENCE, FRANCE: AIX-EN-PROVENCE, FRANCE -- (Marketwired) -- 04/23/15 -- SuperSonic Imagine (EURONEXT PARIS: SSI) (Euronext: SSI, FR0010526814), the highly innovative ultrasound company that pioneered breakthrough Sh ...
TORONTO, ON: TORONTO, ON -- (Marketwired) -- 04/20/15 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) announces it has signed a letter of intent with Colorado Product Services, LLC and Cultiv8, LLC regarding the ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/16/15 -- M Pharmaceutical Inc. (the "Company") (CSE: MQ) clarified today the timing of its previously announced consolidation (the " ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 04/10/15 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 04/06/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and bus ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 04/03/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 04/01/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/31/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...
SEATTLE, WA: Conference Call to Be Held Today at 4:30 pm Eastern Time ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 03/25/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, announced t ...
SOUTH SAN FRANCISCO, CA: FDA Joint Advisory Committee Reviewing Supplemental NDA for BREO(R) ELLIPTA(R) (FF/VI) for Asthma ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/19/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today repor ...
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwired) -- 03/17/15 -- Cytovance® Biologics Inc., a leader in the manufacturing of mammalian and microbial biopharmaceuticals, announced it has received four CMO Leadershi ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 03/12/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, will release its fourth quarter and ye ...
FOSTER CITY, CA: Board of Directors Approves Additional $15 Million for Share Repurchase in 2015 ...
GEORGE TOWN, GRAND CAYMAN: VIBATIV(R) (Telavancin) Commercial Team Expanded in Target Geographies, Registry Study Initiated and Telavancin Phase 3 Bacteremia Study Underway; Pipeline Progressing; TD-4208 Advancing to Phase 3 Re ...
